BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35714370)

  • 1. 68 Ga-FAPI-46 and 18 F-FDG in Advanced Metastatic Pancreatic Cancer.
    Kaghazchi F; Divband G; Amini H; Adinehpour Z; Akbarian Aghdam R
    Clin Nucl Med; 2022 Oct; 47(10):e666-e669. PubMed ID: 35714370
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Kessler L; Hirmas N; Pabst KM; Hamacher R; Ferdinandus J; Schaarschmidt BM; Milosevic A; Nader M; Umutlu L; Uhl W; Reinacher-Schick A; Lugnier C; Witte D; Niedergethmann M; Herrmann K; Fendler WP; Siveke JT
    J Nucl Med; 2023 Dec; 64(12):1910-1917. PubMed ID: 37973185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the clinical value of baseline [
    Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Li X; Huo L
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4036-4050. PubMed ID: 37493664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography and computed tomography with [
    Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of
    Pang Y; Zhao L; Luo Z; Hao B; Wu H; Lin Q; Sun L; Chen H
    Radiology; 2021 Feb; 298(2):393-402. PubMed ID: 33258746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the diagnostic efficacy of
    Zhang Z; Jia G; Pan G; Cao K; Yang Q; Meng H; Yang J; Zhang L; Wang T; Cheng C; Zuo C
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2877-2888. PubMed ID: 35243518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of early and late
    Hoppner J; van Genabith L; Hielscher T; Heger U; Sperling L; Colbatzky T; Gutjahr E; Lang M; Pausch T; Spektor AM; Glatting FM; Liermann J; Hackert T; Kratochwil C; Giesel FL; Haberkorn U; Röhrich M
    Sci Rep; 2023 Oct; 13(1):17848. PubMed ID: 37857656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [
    Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of [
    Kömek H; Can C; Kaplan İ; Gündoğan C; Kepenek F; Karaoglan H; Demirkıran A; Ebinç S; Güzel Y; Gündeş E
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3898-3909. PubMed ID: 35578038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-Tracer PET/CT Protocol with [
    Roth KS; Voltin CA; van Heek L; Wegen S; Schomäcker K; Fischer T; Marnitz S; Drzezga A; Kobe C
    J Nucl Med; 2022 Nov; 63(11):1683-1686. PubMed ID: 35422446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of
    Sayiner ZA; Elboğa U; Sahin E; Ozturk S; Cayirli YB; Celen YZ; Akarsu E; Dogan I; Kilbas B; Eryilmaz K; Cakici D
    Hell J Nucl Med; 2023; 26(1):41-46. PubMed ID: 37115220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using
    Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
    J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of [
    Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of [
    Chen H; Zhao L; Ruan D; Pang Y; Hao B; Dai Y; Wu X; Guo W; Fan C; Wu J; Huang W; Lin Q; Sun L; Wu H
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):73-86. PubMed ID: 32588089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities.
    Hirmas N; Hamacher R; Sraieb M; Ingenwerth M; Kessler L; Pabst KM; Barbato F; Lueckerath K; Kasper S; Nader M; Schildhaus HU; Kesch C; von Tresckow B; Hanoun C; Hautzel H; Aigner C; Glas M; Stuschke M; Kümmel S; Harter P; Lugnier C; Uhl W; Niedergethmann M; Hadaschik B; Grünwald V; Siveke JT; Herrmann K; Fendler WP
    J Nucl Med; 2023 May; 64(5):711-716. PubMed ID: 36581374
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Mei R; Kessler L; Pabst KM; Weber M; Schmidkonz C; Rischpler C; Zacho HD; Hope T; Schwarzenböck SM; Allen-Auerbach M; Emmett L; Ferdinandus J; Unterrainer M; Schaarschmidt BM; Umutlu L; Farolfi A; Castellucci P; Nanni C; Telo S; Fanti S; Herrmann K; Fendler WP
    J Nucl Med; 2023 Jul; 64(7):1043-1048. PubMed ID: 37230530
    [No Abstract]   [Full Text] [Related]  

  • 18. Head-to-Head Comparison of [
    Wegen S; van Heek L; Linde P; Claus K; Akuamoa-Boateng D; Baues C; Sharma SJ; Schomäcker K; Fischer T; Roth KS; Klußmann JP; Marnitz S; Drzezga A; Kobe C
    Mol Imaging Biol; 2022 Dec; 24(6):986-994. PubMed ID: 35771317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [
    Siripongsatian D; Promteangtrong C; Kunawudhi A; Kiatkittikul P; Boonkawin N; Chinnanthachai C; Jantarato A; Chotipanich C
    Mol Imaging Biol; 2022 Oct; 24(5):818-829. PubMed ID: 35486293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of [
    Jiang D; Chen X; You Z; Wang H; Zhang X; Li X; Ren S; Huang Q; Hua F; Guan Y; Zhao J; Xie F
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):732-742. PubMed ID: 34297193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.